Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study

BACKGROUND: Pulmonary microvascular occlusions can aggravate SARS-CoV-2 pneumonia and result in a variable decrease in capillary blood volume (Vc). Dyspnoea may persist for several weeks after hospital discharge in many patients who have "radiologically recovered" from COVID-19 pneumonia....

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W., Turco, Paola, Povero, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830396/
https://www.ncbi.nlm.nih.gov/pubmed/36636645
http://dx.doi.org/10.4081/mrm.2022.886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830396/
https://www.ncbi.nlm.nih.gov/pubmed/36636645
http://dx.doi.org/10.4081/mrm.2022.886

Ejemplares similares